34 59

Cited 0 times in

Protein tyrosine phosphatase 1B as a therapeutic target for Graves' orbitopathy in an in vitro model

 Hyeong Ju Byeon  ;  Ji-Young Kim  ;  JaeSang Ko  ;  Eun Jig Lee  ;  Kikkawa Don  ;  Jin Sook Yoon 
 PLOS ONE, Vol.15(8) : e0237015, 2020-08 
Journal Title
Issue Date
Adult ; Animals ; Apoptosis ; Cattle ; Cell Survival ; Cytokines / biosynthesis ; Endoplasmic Reticulum Stress ; Female ; Fibroblasts / drug effects ; Fibroblasts / metabolism ; Fibroblasts / pathology ; Gene Silencing ; Graves Ophthalmopathy / enzymology* ; Graves Ophthalmopathy / pathology ; Graves Ophthalmopathy / therapy* ; Humans ; In Vitro Techniques ; Inflammation Mediators / metabolism ; Male ; Middle Aged ; Oxidative Stress ; Prefrontal Cortex / drug effects ; Prefrontal Cortex / metabolism ; Prefrontal Cortex / pathology ; Protein Tyrosine Phosphatase, Non-Receptor Type 1 / antagonists & inhibitors* ; Protein Tyrosine Phosphatase, Non-Receptor Type 1 / genetics ; Protein Tyrosine Phosphatase, Non-Receptor Type 1 / metabolism ; RNA, Small Interfering / genetics ; Reactive Oxygen Species / metabolism ; Signal Transduction
Graves' orbitopathy (GO) is characterised in early stages by orbital fibroblast inflammation, which can be aggravated by oxidative stress and often leads to fibrosis. Protein tyrosine protein 1B (PTP1B) is a regulator of inflammation and a therapeutic target in diabetes. We investigated the role of PTP1B in the GO mechanism using orbital fibroblasts from GO and healthy non-GO subjects. After 24 hours of transfection with PTPN1 siRNA, the fibroblasts were exposed to interleukin (IL)-1β, cigarette smoke extract (CSE), H2O2, and transforming growth factor (TGF)-β stimulations. Inflammatory cytokines and fibrosis-related proteins were analysed using western blotting and/or enzyme-linked immunosorbent assay (ELISA). Reactive oxygen species (ROS) release was detected using an oxidant-sensitive fluorescent probe. IL-1β, tumor necrosis factor (TNF)-α, bovine thyroid stimulating hormone (bTSH), high-affinity human stimulatory monoclonal antibody of TSH receptor (M22), and insulin-like growth factor-1 (IGF-1) significantly increased PTP1B protein production in GO and non-GO fibroblasts. PTPN1 silencing significantly blocked IL-1β-induced inflammatory cytokine production, CSE- and H2O2-induced ROS synthesis, and TGF-β-induced expression of collagen Iα, α-smooth muscle actin (SMA), and fibronectin in GO fibroblasts. Silencing PTPN1 also decreased phosphorylation levels of Akt, p38, and c-Jun N-terminal kinase (JNK) and endoplasmic reticulum (ER)-stress response proteins in GO cells. PTP1B may be a potential therapeutic target of anti-inflammatory, anti-oxidant and anti-fibrotic treatment of GO.
Files in This Item:
T202006070.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Ophthalmology (안과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Ko, Jaesang(고재상) ORCID logo https://orcid.org/0000-0002-3011-7213
Yoon, Jin Sook(윤진숙) ORCID logo https://orcid.org/0000-0002-8751-9467
Lee, Eun Jig(이은직) ORCID logo https://orcid.org/0000-0002-9876-8370
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.